{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:35:21Z","timestamp":1790235321751,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.intimp.2019.05.028","type":"journal-article","created":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T12:21:14Z","timestamp":1559046074000},"page":"389-394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Evaluation of topical human platelet lysate versus topical clobetasol in management of methotrexate-induced oral ulceration in rheumatoid arthritis patients: Randomized-controlled clinical trial"],"prefix":"10.1016","volume":"73","author":[{"given":"Eman Magdy","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheir Mohamed","family":"Gaafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laila Mohamed","family":"Rashed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala Lotfy","family":"Fayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2019.05.028_bb0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jdsr.2013.12.001","article-title":"Oral ulcerations due to drug medications","volume":"50","author":"Jinbu","year":"2014","journal-title":"Jpn. Dent. Sci. Rev."},{"key":"10.1016\/j.intimp.2019.05.028_bb0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.oooo.2014.09.009","article-title":"Adverse drug events in the oral cavity","volume":"119","author":"Yuan","year":"2015","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol."},{"key":"10.1016\/j.intimp.2019.05.028_bb0015","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1468-3083.2008.02637.x","article-title":"Oral manifestations of adverse drug reactions: guidelines","volume":"22","author":"Femiano","year":"2008","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.intimp.2019.05.028_bb0020","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/sj.bdj.4811972","article-title":"Methotrexate and oral ulceration","volume":"198","author":"Deeming","year":"2005","journal-title":"Br. Dent. J."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2019.05.028_bb0025","first-page":"S5","article-title":"Mechanisms of action of methotrexate","volume":"71","author":"Chan","year":"2013","journal-title":"Bull. Hosp. Jt Dis."},{"key":"10.1016\/j.intimp.2019.05.028_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.14476\/jomp.2015.40.2.82","article-title":"Methotrexate-induced oral mucositis","volume":"40","author":"Lee","year":"2015","journal-title":"J. Oral Med. Pain"},{"key":"10.1016\/j.intimp.2019.05.028_bb0035","first-page":"e181","article-title":"Management options for low-dose methotrexate-induced oral ulcers: a systematic review","volume":"24","author":"Chamorro-Petronacci","year":"2019","journal-title":"Med. Oral Patol. Oral Cir. Bucal."},{"key":"10.1016\/j.intimp.2019.05.028_bb0040","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1177\/154405910508400401","article-title":"Vesiculo-erosive oral mucosal disease \u2014management with topical corticosteroids: (1) fundamental principles and specific agents available","volume":"84","author":"Gonzalez-Moles","year":"2005","journal-title":"J. Dent. Res."},{"key":"10.1016\/j.intimp.2019.05.028_bb0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1208\/s12249-011-9649-3","article-title":"Platelet lysate mucohadesive formulation to treat oral mucositis in graft versus host disease patients: a new therapeutic approach","volume":"12","author":"Del Fante","year":"2011","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.intimp.2019.05.028_bb0050","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0030-4220(91)90300-2","article-title":"Open preliminary clinical trial of clobetasol propionate ointment in adhesive paste for treatment of chronic oral vesiculoerosive diseases","volume":"71","author":"Lozada-Nur","year":"1991","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"10.1016\/j.intimp.2019.05.028_bb0055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.5005\/jcdp-9-3-88","article-title":"Review of over-the-counter treatments for aphthous ulceration and results from use of a dissolving oral patch containing glycyrrhiza complex herbal extract","volume":"9","author":"Burgess","year":"2008","journal-title":"J. Contemp. Dent. Pract."},{"key":"10.1016\/j.intimp.2019.05.028_bb0060","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/bja\/aen103","article-title":"Assessment of pain","volume":"101","author":"Breivik","year":"2008","journal-title":"Br. J. Anaesth."},{"key":"10.1016\/j.intimp.2019.05.028_bb0065","series-title":"Handbook for Reporting Results of Cancer Treatment","author":"World Health Organization","year":"1979"},{"key":"10.1016\/j.intimp.2019.05.028_bb0070","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1601-0825.2006.01327.x","article-title":"Effectiveness of two oral pastes for the treatment of recurrent aphthous stomatitis","volume":"13","author":"Rodriguez","year":"2007","journal-title":"Oral Dis."},{"key":"10.1016\/j.intimp.2019.05.028_bb0075","doi-asserted-by":"crossref","first-page":"175","DOI":"10.3758\/BF03193146","article-title":"G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences","volume":"39","author":"Faul","year":"2007","journal-title":"Behav. Res. Methods"},{"key":"10.1016\/j.intimp.2019.05.028_bb0080","first-page":"1523","article-title":"Preparation of pooled human platelet lysate (pHPL) as an efficient supplement for animal serum-free human stem cell cultures","volume":"30","author":"Schallmoser","year":"2009","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.intimp.2019.05.028_bb0085","doi-asserted-by":"crossref","first-page":"3","DOI":"10.32098\/mltj.01.2014.02","article-title":"Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives","volume":"4","author":"Dohan Ehrenfest","year":"2014","journal-title":"Muscles Ligaments Tendons J."},{"key":"10.1016\/j.intimp.2019.05.028_bb0090","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s11999-015-4192-2","article-title":"Platelet-rich concentrates differentially release growth factors and induce cell migration in vitro","volume":"473","author":"Sch\u00e4r","year":"2015","journal-title":"Clin. Orthop. Relat. Res."},{"key":"10.1016\/j.intimp.2019.05.028_bb0095","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/ijms19010212","article-title":"Comparative analysis of different platelet lysates and platelet rich preparations to stimulate tendon cell biology: an in vitro study","volume":"19","author":"Klatte-Schulz","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.intimp.2019.05.028_bb0100","unstructured":"C.M. Caramella, M.C. Bonferoni, S.S. Rossi, G. Sandri, F. Ferrari, C.G. Perotti, C. Del Fante, inventors; Universita degli Studi di Pavia, BIOMED DEVICE Srl, assignee. Platelet lysate and bioadhesive compositions thereof for the treatment of mucositis. United States patent application US 13\/149,311. 2011."},{"key":"10.1016\/j.intimp.2019.05.028_bb0105","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/trf.15174","article-title":"Human platelet lysate current standards and future developments","volume":"59","author":"Henschler","year":"2019","journal-title":"Transfusion"},{"issue":"2016","key":"10.1016\/j.intimp.2019.05.028_bb0110","first-page":"1","article-title":"American College of Rheumatology guideline for the treatment of rheumatoid arthritis","volume":"68","author":"Singh","year":"2015","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.intimp.2019.05.028_bb0115","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tripleo.2004.08.020","article-title":"Oral effects of low-dose methotrexate treatment","volume":"100","author":"Kalantzis","year":"2005","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"key":"10.1016\/j.intimp.2019.05.028_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/rheumatology\/keh088","article-title":"Folate supplementation and methotrexate treatment in rheumatoid arthritis: a review","volume":"43","author":"Whittle","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.intimp.2019.05.028_bb0125","article-title":"Folic acid and folinic acid for reducing side effects in patients receiving methotrexate for rheumatoid arthritis","volume":"31","author":"Shea","year":"2013","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2019.05.028_bb0130","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/trf.14594","article-title":"Autologous blood as a source of platelet gel for the effective and safe treatment of oral chronic graft-versus-host disease","volume":"58","author":"Bojanic","year":"2018","journal-title":"Transfusion"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919307659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576919307659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T12:15:15Z","timestamp":1574770515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576919307659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":26,"alternative-id":["S1567576919307659"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2019.05.028","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of topical human platelet lysate versus topical clobetasol in management of methotrexate-induced oral ulceration in rheumatoid arthritis patients: Randomized-controlled clinical trial","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2019.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}